Tagged with S

Dar Al Dawa Development & Investment Dar al Dawa is the second biggest Jordanian pharmaceutical manufacturer. What are the main factors that allowed you to be so successful and remain in one of the top positions since the company’s inception in 1974? The key factor has been Jordan. Being poor in natural recourses, Jordan had to…

Jordan Investment Board The Jordan Investment Board (JIB) has played an important role in boosting the success story of the Jordanian economy since its inception in 1995; today, what are the JIB’s main priorities and objectives? What is currently your core agenda? The JIB attracts FDI to Jordan from all over the world.…

Gulf Organization for Industrial Consulting What was the vision behind the creation of GOIC back in 1976 by the 6 Gulf States (Bahrein, KSA, UAE, Oman, Kuwait and Qatar)? How did you 6 States see the need for such an organization, which is like a knowledge-hub that would promote trade and investment by enabling the…

Hormona Laboratorios Since we last spoke to you in 2008, Mexico has undergone a lot of regulatory changes, and we witnessed the rise of Seguro Popular, and the rise of COFEPRIS for example. What has been the biggest change in the market in the last 4 years, and how have these changes…

Sanofi Pasteur Thailand You moved from the post of President for Sanofi Pasteur in Korea to President of Sanofi Pasteur in Thailand 1,5 years back. What have been the milestones so far and what have been the most important lessons learnt? Thailand is a country of dynamism. Thai people are very professional and…

Quintiles Thailand Asia is rapidly becoming a new frontier for drug development as Western companies seek to develop and register their products in Asia, while emerging Asian companies seek new capabilities to globalize products. We hear a lot of positive sounds and enthusiasm from MNCs about the environment in Thailand: available pool…

AstraZeneca Thailand Dr. Seeto, this is your first head of country position for AZ! Looking back at your first year-and-a-month, what have been the highlights and the key lessons learnt? Firstly, leading the Thai country organization has been a real privilege and honor. Looking back, I am proud of how the country…

IMS Health Turkey Before we start with the interview I noticed that previously you were in charge of other regions aside from turkey. Is that still the case? If not why did IMS decide to separate Turkey from these regions ? Every third or fourth year, according to the growth of each country…

Novo Nordisk Thailand Novo Nordisk is one of the very few pharmaceutical multinationals that have a strong focus on one therapeutic area. Although the company has a presence in other disease areas, diabetes remains its leading cause. Could you give us a brief overview of the evolution of diabetes in Thailand compared to…

Shire Pharmaceuticals Please can you give us a rundown of Shires activities in Mexico in the last four years, and the key achievements and milestones along the way? Shire started operations in Mexico in 2008, a similar story to Brazil. There are very few people working here in Shire Mexico but we…

SinoBioway Group Could you provide us with an introduction to the company and an overview of operations from the company’s founding through to your position today as a leading biotech company in China? The company’s development can be divided into three phases. The first stage ranges from the company’s establishment up till…

Latam Clinical Trials While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of SIPLAS labs and was known at the time as SIPLAS Research Organization. We decided to change our name to LatAm…